Kellie Minasian

Kellie Minasian is a seasoned professional in regulatory affairs with extensive experience in the biopharmaceutical sector. Currently serving as Director of Regulatory Affairs at Seagen since April 2021, Kellie previously held similar roles at Kite Pharma and Atara Biotherapeutics, fostering expertise in the coordination of regulatory submissions, product advancement strategies, and FDA interactions. Earlier positions include US Regulatory Affairs Professional at Amgen and experience as an intern in regulatory science and translational research at the University of Southern California. Kellie's academic credentials include a Master of Science in Management of Drug Development and a Bachelor of Science in Neuroscience, demonstrating a strong foundation in both scientific knowledge and regulatory strategy.